Product Program year 2025 Source: CMS Open Payments

Gallant

Device Cardiac Rhythm Management

PDI 05415067032010

Open in the dashboard

General payments

$842,306

10,065 payments

Research payments

$1,704,920

621 payments

Through program year 2025, $842,306 in general payments and $1,704,920 in research payments were reported against Gallant (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 Research $102,199 45
2024 General $363,996 4,471
2024 Research $270,909 148
2023 General $346,895 4,307
2023 Research $578,099 186
2022 General $131,416 1,287
2022 Research $753,714 242

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $842,306 10,065 payments
Top recipients General payments · program year 2024
  1. Jagmeet Singh Clinical Cardiac Electrophysiology · Boston, MA $19,929 5% · 24 payments
  2. Nitish Badhwar Clinical Cardiac Electrophysiology · Stanford, CA $12,985 4% · 23 payments
  3. Babak Nazer Clinical Cardiac Electrophysiology · Seattle, WA $8,551 2% · 15 payments
  4. Daniel Friedman Clinical Cardiac Electrophysiology · Durham, NC $6,139 2% · 19 payments
  5. Krishna Kancharla Clinical Cardiac Electrophysiology · Pittsburgh, PA $6,001 2% · 19 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Clinical Cardiac Electrophysiology Internal Medicine $148,462 44% · 443 practitioners
  2. Cardiovascular Disease Internal Medicine $69,860 21% · 352 practitioners
  3. Internal Medicine $56,606 17% · 120 practitioners
  4. Interventional Cardiology Internal Medicine $15,725 5% · 161 practitioners
  5. Hospitalist $11,174 3% · 16 practitioners

The top 5 of 64 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $46,300 13% · 173 recipients
  2. Texas $46,086 13% · 259 recipients
  3. Illinois $25,474 7% · 48 recipients
  4. Massachusetts $23,160 6% · 15 recipients
  5. Florida $21,289 6% · 125 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

10,065 general · 621 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record